Flowchart of the 3-step development of a personalized approach to guide HSCT indication in CR1, successively integrating ELN 2017 risk, NPM1 MRD, and KB score threshold. The subsets of patients assigned to the chemotherapy-only and the HSCT postremission strategies at each step are indicated by blue and red boxes, respectively.